Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema

NCT00676884 is registered in ClinicalTrials.gov with Aerovance, Inc. as lead sponsor.

NCT NCT00676884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00676884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema
Lead sponsor
Aerovance, Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2006
Completion date
August 31, 2006
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic eczema